Aripiprazole inhibits polyI:C-induced microglial activation possibly via TRPM7

Schizophr Res. 2016 Dec;178(1-3):35-43. doi: 10.1016/j.schres.2016.08.022. Epub 2016 Sep 7.

Abstract

Viral infections during fetal and adolescent periods, as well as during the course of schizophrenia itself have been linked to the onset and/or relapse of a psychosis. We previously reported that the unique antipsychotic aripiprazole, a partial D2 agonist, inhibits the release of tumor necrosis factor (TNF)-α from interferon-γ-activated rodent microglial cells. Polyinosinic-polycytidylic acid (polyI:C) has recently been used as a standard model of viral infections, and recent in vitro studies have shown that microglia are activated by polyI:C. Aripiprazole has been reported to ameliorate behavioral abnormalities in polyI:C-induced mice. To clarify the anti-inflammatory properties of aripiprazole, we investigated the effects of aripiprazole on polyI:C-induced microglial activation in a cellular model of murine microglial cells and possible surrogate cells for human microglia. PolyI:C treatment of murine microglial cells activated the production of TNF-α and enhanced the p38 mitogen-activated protein kinase (MAPK) pathway, whereas aripiprazole inhibited these responses. In addition, polyI:C treatment of possible surrogate cells for human microglia markedly increased TNF-α mRNA expression in cells from three healthy volunteers. Aripiprazole inhibited this increase in cells from two individuals. PolyI:C consistently increased intracellular Ca2+ concentration ([Ca2+]i) in murine microglial cells by influx of extracellular Ca2+. We demonstrated that transient receptor potential in melastatin 7 (TRPM7) channels contributed to this polyI:C-induced increase in [Ca2+]i. Taken together, these data suggest that aripiprazole may be therapeutic for schizophrenia by reducing microglial inflammatory reactions, and TRPM7 may be a novel therapeutic target for schizophrenia. Further studies are needed to validate these findings.

Keywords: Antipsychotics; Infection; Microglia; Polyriboinosinic-polyribocytidylic acid (polyI:C); Schizophrenia; Transient receptor potential melastatin 7 (TRPM7).

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Antipsychotic Agents / pharmacology*
  • Aripiprazole / pharmacology*
  • Brain / cytology
  • Brain / drug effects
  • Brain / immunology
  • Calcium / metabolism
  • Cations, Divalent / metabolism
  • Cells, Cultured
  • Humans
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Male
  • Mice, Inbred C57BL
  • Microglia / cytology
  • Microglia / drug effects*
  • Microglia / immunology*
  • Poly I-C / toxicity
  • Protein Serine-Threonine Kinases / metabolism
  • RNA, Messenger / metabolism
  • TRPM Cation Channels / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antipsychotic Agents
  • Cations, Divalent
  • RNA, Messenger
  • TRPM Cation Channels
  • Tumor Necrosis Factor-alpha
  • Aripiprazole
  • Trpm7 protein, mouse
  • Protein Serine-Threonine Kinases
  • TRPM7 protein, human
  • p38 Mitogen-Activated Protein Kinases
  • Poly I-C
  • Calcium